Literature DB >> 12180122

Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes.

Rabea K L Bouhafs1, Connie Jarstrand.   

Abstract

Production of oxygen radicals by stimulated phagocytes followed by surfactant lipid peroxidation (LPO) and loss of surfactant function have all been implicated in the pathogenesis of acute lung injury. We studied the interactions between natural lung surfactant (Curosurf) and neutrophils in vitro, and compared various antioxidants; (superoxide dismutase (SOD), vitamin E, vitamin C, ebselen and melatonin), or combinations of them in duplicate and triplicate regarding their ability to decrease superoxide production and the peroxidation level of surfactant caused by activated phagocytes. The superoxide production of neutrophils activated by Candida albicans was measured with the nitroblue tetrazolium (NBT) test. The subsequent LPO was estimated as the content of malondialdehyde (MDA) and 4-hydroxyalkenals (4-HNE). We found that lung surfactant decreased the superoxide production by activated neutrophils (29.7%) and that Curosurf was peroxidized with elevated MDA/4-HNE values. With supplements of antioxidants (except vitamin C), superoxide radical production and the surfactant LPO level fell in a dose-dependent manner. The protective effect of the antioxidants differed in each test. SOD had a slight effect in both tests. The findings with vitamin E, melatonin and ebselen were similar. The best combination was that of a natural and a synthetic antioxidant (melatonin-ebselen) with a 60% decrease in comparison to the corresponding control. These findings suggest that antioxidants, particularly in combination, prevent LPO of lung surfactant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12180122     DOI: 10.1080/10715760290032593

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  14 in total

Review 1.  Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders.

Authors:  Adam Wichniak; Aleksander Kania; Mariusz Siemiński; Wiesław Jerzy Cubała
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

2.  Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.

Authors:  R K L Bouhafs; C Jarstrand; B Robertson
Journal:  Lung       Date:  2004       Impact factor: 2.584

3.  Ebselen improves ischemia-reperfusion injury after rat lung transplantation.

Authors:  Jürg Hamacher; Uz Stammberger; Elvira Weber; Rudolf Lucas; Albrecht Wendel
Journal:  Lung       Date:  2009-02-07       Impact factor: 2.584

Review 4.  Dietary Sources and Bioactivities of Melatonin.

Authors:  Xiao Meng; Ya Li; Sha Li; Yue Zhou; Ren-You Gan; Dong-Ping Xu; Hua-Bin Li
Journal:  Nutrients       Date:  2017-04-07       Impact factor: 5.717

Review 5.  Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.

Authors:  Virna Margarita Martín Giménez; Felipe Inserra; Carlos D Tajer; Javier Mariani; León Ferder; Russel J Reiter; Walter Manucha
Journal:  Life Sci       Date:  2020-05-15       Impact factor: 5.037

6.  Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome.

Authors:  Jana Kopincova; Maros Kolomaznik; Pavol Mikolka; Petra Kosutova; Juliana Topercerova; Katarina Matasova; Andrea Calkovska; Daniela Mokra
Journal:  Molecules       Date:  2019-03-05       Impact factor: 4.411

7.  Short-Term versus Long-Term Culture of A549 Cells for Evaluating the Effects of Lipopolysaccharide on Oxidative Stress, Surfactant Proteins and Cathelicidin LL-37.

Authors:  Zuzana Nova; Henrieta Skovierova; Jan Strnadel; Erika Halasova; Andrea Calkovska
Journal:  Int J Mol Sci       Date:  2020-02-09       Impact factor: 5.923

Review 8.  Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?

Authors:  Ahilanandan Dushianthan; Rebecca Cusack; Victoria Goss; Anthony D Postle; Mike P W Grocott
Journal:  Crit Care       Date:  2012-11-22       Impact factor: 9.097

Review 9.  Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy.

Authors:  Summer R Hayek; Samuel A Lee; Karlett J Parra
Journal:  Front Pharmacol       Date:  2014-01-27       Impact factor: 5.810

10.  Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug?

Authors:  Stephen Y W Shiu; Russel J Reiter; Dun-Xian Tan; Shiu F Pang
Journal:  J Pineal Res       Date:  2003-08       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.